Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3A | Q14432 | 3/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.47 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 5/20 | 0.47 |
| ▸ | MTOR | P42345 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.47 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.47 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.47 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.40 |
| ▸ | ALB | P02768 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.40 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.40 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | DNMT1 | P26358 | 2/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28379714 | 1.00 | PDE3A (0.47) | PDE3APDE4DSLC29A1LMNAMTOR | |
| Phosphoric Acid SCHEMBL6141725 | 0.95 | PDE3A (0.44) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL3424602 | 0.85 | PDE3A (0.47) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL992472 | 0.84 | PDE3A (0.46) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL3038818 | 0.84 | PDE3A (0.52) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL7794942 | 0.84 | PDE3A (0.46) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL4971926 | 0.84 | PDE3A (0.46) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL51650 | 0.84 | PDE3A (0.46) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL27544566 | 0.84 | PDE3A (0.46) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL3449198 | 0.84 | PDE3A (0.46) | PDE3APDE4DSLC29A1LMNAMTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713450-A1 | ENGINEERED CONSTRUCTS WITH CASSETTE ARRANGEMENTS FOR INCREASED TRANSCRIPTION OF RNA PAYLOADS | Shape Therapeutics Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| EP-4652278-A1 | POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER | Aptah Bio, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| EP-4652277-A1 | POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | Aptah Bio, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| CN-120129532-A | Stabilized lipid or lipid nanoparticle suspensions | 埃泽瑞斯公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-119789852-A | Compositions and methods for delivering RNA | 再生技术有限责任公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119317714-A | Nucleic acid modified biological cells with amplification-dependent gene expression | 蒂宾根大学医学院 | 2025-01-14 | — | — | CN | disclosed |
| CN-113423418-B | Treatment of cilia disease | 埃泽瑞斯公司 | 2025-01-10 | — | — | CN | disclosed |
| WO-2024238584-A1 | ENGINEERED CONSTRUCTS WITH CASSETTE ARRANGEMENTS FOR INCREASED TRANSCRIPTION OF RNA PAYLOADS | SHAPE THERAPEUTICS INC. (US) | 2024-11-21 | — | — | WO | disclosed |
| CN-118949075-A | Treatment of cilia disease | 埃泽瑞斯公司 | 2024-11-15 | — | — | CN | disclosed |
| US-20240271134-A1 | OLIGONUCLEOTIDES AND COMPOSITIONS THEREOF FOR NEUROMUSCULAR DISORDERS | MIRECULE INC (US) | 2024-08-15 | — | — | US | disclosed |
| WO-2009046739-A1 | COMPOSITION FOR TREATING PROSTATE CANCER (PCA) | CUREVAC GMBH (DE) | 2009-04-16 | — | — | WO | disclosed |
| WO-2009046738-A1 | COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC) | CUREVAC GMBH (DE) | 2009-04-16 | — | — | WO | disclosed |
| WO-1994022893-A1 | OLIGONUCLEOSIDE LINKAGES CONTAINING ADJACENT NITROGEN ATOMS | ISIS PHARMACEUTICALS, INC. (US) | 1994-10-13 | — | — | WO | disclosed |
| WO-1994022894-A1 | BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS AND PREPARATION THEREOF THROUGH RADICAL COUPLING | ISIS PHARMACEUTICALS, INC. (US) | 1994-10-13 | — | — | WO | disclosed |
| US-5210203-A | Sulfonamide-derivative compounds for tagging nucleic acid probes | SISKA DIAGNOSTICS, INC. (US) | 1993-05-11 | — | — | US | disclosed |
| EP-0439550-A4 | DNA SEQUENCING BY MULTIPLE MIXED OLIGONUCLEOTIDE PROBES | — | 1991-09-25 | — | — | EP | disclosed |
| EP-0439550-A1 | DNA SEQUENCING BY MULTIPLE MIXED OLIGONUCLEOTIDE PROBES | DNAX RESEARCH INSTITUTE OF MOLECULAR AND CELLULAR BIOLOGY, INC. (US) | 1991-08-07 | — | — | EP | disclosed |
| WO-1990004652-A1 | DNA SEQUENCING BY MULTIPLE MIXED OLIGONUCLEOTIDE PROBES | DNAX RESEARCH INSTITUTE OF MOLECULAR AND CELLULAR BIOLOGY, INC. (US) | 1990-05-03 | — | — | WO | disclosed |
| EP-0210021-A2 | Carbonic anhydrase inhibitor-tagged nucleic acid probes | SISKA DIAGNOSTICS,INC. (US) | 1987-01-28 | — | — | EP | disclosed |
| EP-0209996-A2 | Nucleic acid probes comprising N4 -(substituted amino)cytidines | SISKA DIAGNOSTICS,INC. (US) | 1987-01-28 | — | — | EP | disclosed |